Literature DB >> 32055808

An adaptable soft-mold embossing process for fabricating optically-accessible, microfeature-based culture systems and application toward liver stage antimalarial compound testing.

Steven P Maher1, Amy J Conway2, Alison Roth2, Swamy R Adapa2, Phillip Cualing2, Chiara Andolina3, James Hsiao4, Jessica Turgeon2, Victor Chaumeau3, Myles Johnson2, Chris Palmiotti4, Naresh Singh2, Samantha J Barnes2, Raahil Patel2, Virginia Van Grod4, Robert Carter2, H-C Steve Sun4, Jetsumon Sattabongkot5, Brice Campo6, François Nosten3, Wajeeh M Saadi4, John H Adams2, Rays H Y Jiang2, Dennis E Kyle1.   

Abstract

Advanced cell culture methods for modeling organ-level structure have been demonstrated to replicate in vivo conditions more accurately than traditional in vitro cell culture. Given that the liver is particularly important to human health, several advanced culture methods have been developed to experiment with liver disease states, including infection with Plasmodium parasites, the causative agent of malaria. These models have demonstrated that intrahepatic parasites require functionally stable hepatocytes to thrive and robust characterization of the parasite populations' response to investigational therapies is dependent on high-content and high-resolution imaging (HC/RI). We previously reported abiotic confinement extends the functional longevity of primary hepatocytes in a microfluidic platform and set out to instill confinement in a microtiter plate platform while maintaining optical accessibility for HC/RI; with an end-goal of producing an improved P. vivax liver stage culture model. We developed a novel fabrication process in which a PDMS soft mold embosses hepatocyte-confining microfeatures into polystyrene, resulting in microfeature-based hepatocyte confinement (μHEP) slides and plates. Our process was optimized to form both microfeatures and culture wells in a single embossing step, resulting in a 100 μm-thick bottom ideal for HC/RI, and was found inexpensively amendable to microfeature design changes. Microfeatures improved intrahepatic parasite infection rates and μHEP systems were used to reconfirm the activity of reference antimalarials in phenotypic dose-response assays. RNAseq of hepatocytes in μHEP systems demonstrated microfeatures sustain hepatic differentiation and function, suggesting broader utility for preclinical hepatic assays; while our tailorable embossing process could be repurposed for developing additional organ models.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32055808     DOI: 10.1039/c9lc00921c

Source DB:  PubMed          Journal:  Lab Chip        ISSN: 1473-0189            Impact factor:   6.799


  7 in total

1.  A Phenotypic Screen for the Liver Stages of Plasmodium vivax.

Authors:  Steven P Maher; Amélie Vantaux; Caitlin A Cooper; Nathan M Chasen; Wayne T Cheng; Chester J Joyner; Roman Manetsch; Benoît Witkowski; Dennis Kyle
Journal:  Bio Protoc       Date:  2021-12-05

Review 2.  In vitro models for human malaria: targeting the liver stage.

Authors:  Ana Lisa Valenciano; Maria G Gomez-Lorenzo; Joel Vega-Rodríguez; John H Adams; Alison Roth
Journal:  Trends Parasitol       Date:  2022-06-30

3.  Characterization of the Tubovesicular Network in Plasmodium vivax Liver Stage Hypnozoites and Schizonts.

Authors:  Kayla Sylvester; Steven P Maher; Dora Posfai; Michael K Tran; McKenna C Crawford; Amélie Vantaux; Benoît Witkowski; Dennis E Kyle; Emily R Derbyshire
Journal:  Front Cell Infect Microbiol       Date:  2021-06-14       Impact factor: 5.293

4.  Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites.

Authors:  Dorjbal Dorjsuren; Richard T Eastman; Anton Simeonov; David A Fidock; Kathryn J Wicht; Daniel Jansen; Daniel C Talley; Benjamin A Sigmon; Alexey V Zakharov; Norma Roncal; Andrew T Girvin; Yevgeniya Antonova-Koch; Paul M Will; Pranav Shah; Hongmao Sun; Carleen Klumpp-Thomas; Sachel Mok; Tomas Yeo; Stephan Meister; Juan Jose Marugan; Leila S Ross; Xin Xu; David J Maloney; Ajit Jadhav; Bryan T Mott; Richard J Sciotti; Elizabeth A Winzeler; Norman C Waters; Robert F Campbell; Wenwei Huang
Journal:  Sci Rep       Date:  2021-01-22       Impact factor: 4.379

5.  Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro.

Authors:  Steven P Maher; Amélie Vantaux; Victor Chaumeau; Adeline C Y Chua; Caitlin A Cooper; Chiara Andolina; Julie Péneau; Mélanie Rouillier; Zaira Rizopoulos; Sivchheng Phal; Eakpor Piv; Chantrea Vong; Sreyvouch Phen; Chansophea Chhin; Baura Tat; Sivkeng Ouk; Bros Doeurk; Saorin Kim; Sangrawee Suriyakan; Praphan Kittiphanakun; Nana Akua Awuku; Amy J Conway; Rays H Y Jiang; Bruce Russell; Pablo Bifani; Brice Campo; François Nosten; Benoît Witkowski; Dennis E Kyle
Journal:  Sci Rep       Date:  2021-10-07       Impact factor: 4.379

Review 6.  Advancing Key Gaps in the Knowledge of Plasmodium vivax Cryptic Infections Using Humanized Mouse Models and Organs-on-Chips.

Authors:  Iris Aparici Herraiz; Hugo R Caires; Óscar Castillo-Fernández; Núria Sima; Lourdes Méndez-Mora; Ruth M Risueño; Jetsumon Sattabongkot; Wanlapa Roobsoong; Aurora Hernández-Machado; Carmen Fernandez-Becerra; Cristina C Barrias; Hernando A Del Portillo
Journal:  Front Cell Infect Microbiol       Date:  2022-07-04       Impact factor: 6.073

7.  Single-cell RNA profiling of Plasmodium vivax-infected hepatocytes reveals parasite- and host- specific transcriptomic signatures and therapeutic targets.

Authors:  Anthony A Ruberto; Steven P Maher; Amélie Vantaux; Chester J Joyner; Caitlin Bourke; Balu Balan; Aaron Jex; Ivo Mueller; Benoit Witkowski; Dennis E Kyle
Journal:  Front Cell Infect Microbiol       Date:  2022-08-25       Impact factor: 6.073

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.